Smart Givers Blog
Donate to Charities Review Council
Sign up for our E-Newsletter
Search for organization to which you may donate a car or goods

Follow us on Twitter Follow us on Facebook

Karen Wyckoff Rein In Sarcoma Foundation

The Karen Wyckoff Rein in Sarcoma Foundation’s mission is to fund research that leads to a cure for sarcoma cancers, provide education for medical personnel and the public, and support patients, their loved ones, and others touched by sarcoma.

Mission Statement
Review Completed: 9/29/2011
3312 Richmond Avenue
Shoreview, MN 55126
Phone: 651-486-9114
Fax: 651-486-9114
Other Names Used Rein in Sarcoma
EIN 20-0811343
Principal Staff Peter Wyckoff, President
Number of Full-Time Equivalents (FTE) 0
Number of Volunteers 250
Number of Clients Served 300
Donated Goods Accepts donated goods
General Information
Board Chair Peter Wyckoff
Number of Board Members 15
Board meetings with quorum 5
Average Member Attendance at Board Meetings 10.2
Publicly Available Documents Most Recent 990
Board
Accomplishments
We completed a SWAT analysis of the organization and drafted a new strategic plan. We funded over $153,000 in new sarcoma research grants Began to develop Red Flags Campaign Held two RIS Gathering for sarcoma patients and lived ones with attendance of 40 and 95 people. Very well received
Current Goals
Adopt New Strategic Plan Increase research Funding Increase patient support Update organizational structure Establish a organizational Transition Committee to develop recommendations for long term sustaining of RIS. Develop and institute new Contact Relationship Manager (CRM) system for Foundation.
Community or Constituency Served
Sarcoma cancer patients, survivors, loved ones and those who have lost someone to sarcoma cancers
Geographic Area Served
Minnesota and Upper Midwest (MN, WI, ND, SD, Iowa, Montana)
Impact and Programs

3 Year Average Expenses

Program Services: $131,356 96.4%
Management: $4,933 3.6%
Fundraising: $0 %

Unrestricted Net Assets

2010 2009 2008
End of Year: $210,741 $209,863 $174,860
Beginning of Year $209,863 $174,860 $138,257
Difference $878 $35,003 $36,603
Unrestricted Net Assets (End of Year), Current 990 $210,741
Based on information provided on 2008 to 2010
Financials
Show all standards met
List of Standards Met